Mar 27, 2024 Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update Learn More
Mar 20, 2024 Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024 Learn More
Mar 4, 2024 Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer Learn More